Despite improvements in neuroblastoma treatment, survival figures lag behind those of many other childhood malignancies. New ...

She noted the survival benefit with the combination was achieved even though 38% of patients in the enzalutamide-alone arm ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted ...

Johnson Winter Slattery (JWS) has assisted three of the lead investors in AdvanCell’s US$112m Series C financing effort.

In connection with the release of the results for the full year and fourth quarter 2024, Oncoinvent invites to the following events: ...

NASA is developing a groundbreaking spacecraft concept designed to revolutionize Mars travel. The ambitious plan involves ...

The goal of conducting a fast-tracked nuclear test can only be political, not scientific. The United States has much to lose ...

We are interested in the manuscripts identifying the potential of various radionuclide imaging with promising potential in the diagnosis of various neuroinflammatory and brain disorders. Articles that ...

GU ASCO annual meeting featured a kidney cancer trials in progress session and a presentation by Dr. Eric Jonasch discussing a phase 1b/2 study of combination 177Lu girentuximab + cabozantinib and ...

The FDA makes furthering moves in SCLC, ovarian, and breast cancers, and the value of remote clinical pharmacists is explored in community oncology.

Despite similar availability of diagnostic technologies to women of different racial and ethnic groups, significant disparities were seen in who actually received same-day diagnostic services and ...